About AIM ImmunoTech (AIM)
AIM ImmunoTech Inc. is an immuno-pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship produc... Read more
- USD0.31
- USD0.32
- USD0.29
- USD0.62
- -1.50%
- 0M
- 100.00
- 164.93k
- 17M
- 0.25
- -50.70%
Stock News
3 hours ago
Japan’s Icom says it hasn’t sold walkie-talkies that exploded in Lebanon in a decade
MarketWatch
4 hours ago
DA Davidson Names Meta Platforms, Inc. (META) a Top Mega-Cap Pick
Yahoo
4 hours ago
Broadcom Inc. (AVGO): Benchmark Recommends Buy Despite Tepid AI Momentum
Yahoo
4 hours ago
Palantir Technologies Inc. (PLTR) Secures Multi-Year AI Contract with Nebraska Medicine to Revolutionize Healthcare Operations
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
